[
  {
    "ts": null,
    "headline": "Medtech M&A took off in the second half of 2025: report",
    "summary": "Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.",
    "url": "https://finnhub.io/api/news?id=07cda2a558b240a6fd74620d80e2bb240e85b771d3fc647258731dd3702e10a3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769600763,
      "headline": "Medtech M&A took off in the second half of 2025: report",
      "id": 138285163,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.",
      "url": "https://finnhub.io/api/news?id=07cda2a558b240a6fd74620d80e2bb240e85b771d3fc647258731dd3702e10a3"
    }
  },
  {
    "ts": null,
    "headline": "Why Analysts Are Rethinking The Story Behind Hologic (HOLX) After New Price Targets",
    "summary": "Hologic is back in focus as analysts update their price targets, reflecting a fresh read on the company and its current positioning in the market. This shift in target is tied directly to the latest narrative around Hologic, with recent commentary reshaping how some investors are thinking about the stock today. Continue reading to see how you can stay on top of these narrative changes and what to watch for the next time the story moves. Analyst Price Targets don't always capture the full...",
    "url": "https://finnhub.io/api/news?id=caec542698e3a2d6e91ec9f0135935eb81269fd2e3c39f5859d75a2c402423ec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769587888,
      "headline": "Why Analysts Are Rethinking The Story Behind Hologic (HOLX) After New Price Targets",
      "id": 138279193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Hologic is back in focus as analysts update their price targets, reflecting a fresh read on the company and its current positioning in the market. This shift in target is tied directly to the latest narrative around Hologic, with recent commentary reshaping how some investors are thinking about the stock today. Continue reading to see how you can stay on top of these narrative changes and what to watch for the next time the story moves. Analyst Price Targets don't always capture the full...",
      "url": "https://finnhub.io/api/news?id=caec542698e3a2d6e91ec9f0135935eb81269fd2e3c39f5859d75a2c402423ec"
    }
  },
  {
    "ts": null,
    "headline": "Hologic (HOLX) Q4 Earnings: What To Expect",
    "summary": "Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Thursday after market hours. Here’s what you need to know.",
    "url": "https://finnhub.io/api/news?id=60aac8fbae6cf61ce1ed5efbfdf793e8e24d05ff23005dc4cab1a3593a35e858",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769569805,
      "headline": "Hologic (HOLX) Q4 Earnings: What To Expect",
      "id": 138277654,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Medical technology company Hologic (NASDAQ:HOLX) will be reporting earnings this Thursday after market hours. Here’s what you need to know.",
      "url": "https://finnhub.io/api/news?id=60aac8fbae6cf61ce1ed5efbfdf793e8e24d05ff23005dc4cab1a3593a35e858"
    }
  }
]